Further experiments in ATRA-treated APL patients showed that ATRA directly targeted PML-RARAα and led to granulocyte differentiation and that the expression of the SNORD112-114 gene cluster in the DLK1-DIO3 site decreased during the process.44 The gene discussed is DLK1; the disease is acute promyelocytic leukemia.